starts

Nicholas Wu, USA TODAY Published 7:52 a.m. ET July 9, 2020 | Updated 9:37 a.m. ET July 9, 2020CLOSE Cities across the country followed Washington D.C.'s lead by painting "Black Lives Matter" and other words of support on city streets. USA TODAYNew York City started painting a Black Lives Matter mural Thursday on Fifth Avenue…

FRANKFURT (Reuters) - Unlisted German biotech firm CureVac will become the second company after rival BioNTech 22UAy to launch human trials of an experimental coronavirus vaccine in the country, eyeing a potential approval in mid-2021. The trial launch, first reported by Reuters on Tuesday, will see 144 participants in Germany and Belgium receive different dosages…

On Friday afternoon, President Donald Trump attempted to backtrack on a tweet that appeared to threaten violence against black Americans protesting the police killing of George Floyd in Minneapolis, Minnesota. Earlier in the day, Trump insinuated that he would bring in the military to quell any violence or looting if the situation wasn’t brought under…

Novavax Inc said on Monday it has started the Phase 1 clinical trial of a novel coronavirus vaccine candidate and has enrolled the trial’s first participants, with preliminary results slated for July. Subscribe: http://smarturl.it/reuterssubscribeReuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is…

Dr. Sonia Macieiewski (R) and Dr. Nita Patel, Director of Antibody discovery and Vaccine development, look at a sample of a respiratory virus at Novavax labs in Rockville, Maryland on March 20, 2020, one of the labs developing a vaccine for the coronavirus, COVID-19.Andrew Caballero-Reynolds | AFP | Getty ImagesNovavax said on Monday it has…